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Abstract  
BACKGROUND: Thirty-three percent of infertility due to paternal factors, there are an increasing proportion of 
couples who decide to conceive by assisted reproductive techniques (ART). The outcome prediction is pivotal for 
decision making.  
AIM: We aimed to study the pregnancy outcomes of different ART with male factors infertility. 
METHODS: This is retrospective cross-sectional study conducted at Tabuk, Kingdom of Saudi Arabia. One 
hundred fifteen patients' records reviewed using a structured checklist to collect demographic data, sperm 
(concentration, motility, and morphology). Female with significant infertility factor were excluded. Chi-square was 
used for the outcome of various ART. 
RESULTS: Out of 115 couples with male factors; treated by Intracytoplasmic Sperm Injection (ICSI), In Vitro 
Fertilization (IVF) and Intrauterine Insemination (IUI); the mean age was 35.2 ± 6.3 years for men and 29.7 ± 5.1 
for females. IVF had the highest success rate overall and had a high pregnancy rate with oligospermia and 
asthenospermia. ICSI has a good outcome for those with azoospermia, severe oligospermia, and 
teratozoospermia. IUI must be tried as a first line treatment when semen concentration is more than 10 million 
sperm/ml. all are not significant (P > 0.05). 
CONCLUSION: No significant differences were reported in the pregnancy outcome between various assisted 
reproductive techniques, smoking, type of infertility and medication. 
 
 
 
 
 
Introduction 
 
Infertility is a serious health problem in the 
Kingdom of Saudi Arabia; it accounts for 19% in some 
regions [1]. More than half million couples are waiting 
for assisted reproductive technology. Male factor 
infertility is a term that means the problem in couples 
is due to a male partner. Only a limited number of 
men with primary male factor infertility have potentially 
treatable conditions. However, assisted reproductive 
techniques (ART) are more hopeful than any other 
treatment option. Little information is available 
regarding male factor infertility and its treatment in the 
Kingdom of Saudi Arabia; we found a single study 
published by (Haifa et al.), it indicated that abnormal 
semen parameters were present in 47% of men 
attending infertility clinic [2], whereas worldwide it 
accounts for one-third of cases of infertility [3].
  
Semen analysis is the first step in 
investigating male factor infertility. It is a simple and a 
useful test up to now. The World Health Organization 
(WHO) classification for male factors infertility was 
based on a variety of sperm disorders in which the 
cut-off values are; sperm concentration 15 million 
sperm/ml (oligospermia), total sperm motility 40% 
(asthenospermia) and normal forms 4% 
(teratozoospermia) [4]. There is little agreement about 
the best predictor of pregnancy outcome in various 
seminal abnormalities. Data suggest that IUI improves 
pregnancy rates in couples with mild oligospermia 
(10-15 million sperm/ml) [5, 6]. IVF was used for the 
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treatment of male infertility in patients with moderate 
oligospermia (5-10 million sperm/ml). However, in 
severe oligospermia (< 5 million sperm/ml) and poor 
sperm motility, the fertilization rate of the oocytes was 
much less [7, 8]. Intracytoplasmic Sperm Injection 
(ICSI) has revolutionalized the treatment and 
improved the prognosis for infertile men with very 
severe oligospermia, asthenospermia, 
teratozoospermia, and even azoospermia [9, 10]. 
Although Male infertility is a universal health 
issue, and it is important to understand its aetiology 
and treatment, it is understudied in the kingdom of 
Saudi Arabia. The literature regarding the best 
method of assisted reproductive technology for male 
factor infertility is scarce, to our best of knowledge, 
this is the first study to address this important issue in 
Tabuk City.  
Thus we conducted this research to evaluate 
the outcomes of different assisted reproductive 
technology (IUI, IVF, and ICSI) in couple with male 
factor infertility.  
 
 
Subjects and Methods  
 
A cross-sectional descriptive, longitudinal, 
hospital-based study was conducted from May 2012 
to May 2014. All patients who underwent different 
types of assisted reproductive techniques (IUI, IVF or 
ICSI) for male factor infertility at Prince Khalid bin 
Sultan Fertility Centre in King Salman Armed Force 
Hospital was included. This centre was randomly 
chosen from the three centres in Tabuk City.  
The records of one hundred and fifteen 
patients were reviewed. Inclusion Criteria were: 
infertile male partner due to seminal abnormalities. 
Significant female factor infertility contributing to the 
couple's infertility and couples unsuitable for IUI, IVF 
or ICSI were excluded. The patient's privacy was 
ensured during data collection. A structured checklist 
was used to collect the following parameters: 
Demographic data, sperm concentration, sperm 
motility, and sperm morphology. The cycles with 
embryo transfer were considered. All the males were 
soldiers. Then comparisons were undertaken between 
the above mentioned seminal parameters in the 
patient with male factors infertility and the outcome of 
various assisted reproductive techniques  
For this research the following definitions 
were adopted:  
1) Assisted reproductive technology 
(ART): Describes clinical and laboratory techniques 
used to achieve pregnancy in infertile couples
 
[11].
  
2) Intrauterine insemination (IUI): Is the first 
therapeutic step in assisted reproductive techniques, 
and is especially appropriate for cases with mild male 
factor infertility, anovulation, endometriosis with at 
least one patent tube, and unexplained infertility 
[12].This technique uses a thin flexible catheter to 
place a prepared semen sample into the uterine cavity 
transcervical near the anticipated time of ovulation 
with or without superovulation.  
3) In vitro fertilization (IVF): Mature oocytes 
from stimulated ovaries are retrieved transvaginally 
with ultrasound, and then fertilization in the laboratory 
("in vitro") will be undertaken, after which, one or more 
of the embryos are transferred transcervical into the 
uterine cavity using ultrasound guidance.  
4) Intracytoplasmic sperm injection (ICSI): 
This variation of IVF is most applicable to male factor 
infertility. During this technique, cumulus cells 
surrounding an ovum are enzymatically digested, and 
a single sperm is directly injected into the cytoplasm 
of a mature oocyte
 
[13].  
5) Mild oligospermia (10-15 million 
sperm/ml), Moderate (5 - 10 million sperm/ml) and 
severe (< 5 million sperm/ml) [5, 6].
  
 
Ethical considerations  
The ethical committees of both the University 
of Tabuk and King Salman Armed Force Hospital 
approved the research. The collected data were 
approached confidentially and were used only for 
research. Data were analysed by using the Statistical 
Package for Social Sciences software (SPSS version 
20). The chi-square was used for testing the statistical 
significance, data were presented as percentages or 
mean ± SD, and a P-value < 0.05 was considered as 
statistically significant.  
 
 
Results 
 
Out of 115 couples with male factor infertility, 
the male and females ages were 35.2 ± 6.3 and 29.7 
± 5.1 years respectively. The mean duration of 
infertility was 6.5 ± 4.2 years; sperm concentration 
was 12.1 ± 6.4 million/ml, total sperm motility was 
25.6 ± 23.8 while normal sperm form constituted 15.8 
± 13.6 (Table 1).  
Table 1: Basic characteristics of the study group (n = 115) 
Character Mean ± SD 
Husband age  35.2 ± 6.3 
Wife age  29.7 ± 5.1 
Duration of infertility (years)  6.5 ± 4.2 
Sperm concentration (millions)  12.1 ± 6.4 
Total sperm motility%  25.6 ± 23.8 
Normal sperm form  15.8 ± 13.6 
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The overall pregnancy rate in different 
Assisted Reproductive Technology was reported to be 
46.4% for IVF compared to ICSI and IUI which are 
35.5 and 16% respectively (P = 0.061). 
 
Figure 1: Outcome in the different types of Assisted Reproductive 
Technology (n = 115) 
 
Figure 2 illustrated the outcome in ICSI with 
azoospermic patients (pregnancy rate of 36.7%). 
 
Figure 2: Outcome of ICSI in patient with azoospermia (n = 30) 
 
The outcome of a different semen 
concentration showed that ICSI is more efficient 
(pregnancy rate 24.2%) than the other methods when 
the level below 5 million sperm/ml. In the patients of 
IUI group, there is no pregnancy when the 
concentration is below ten million sperm/ml (Table 2). 
Table 2: Pregnancy rate according to different semen 
concentration 
Semen concentration 
(million sperm/ml)  
Pregnant rate% 
ICSI (n = 62) IVF (n = 28) IUI (n = 25) 
<5 24.2% 7.1% 0 
5-10  1.6% 10.7%  
0     
10-15  6.5% 14.3% 8% 
>15  3.2% 14.3% 8% 
 
Table 3 illustrated the pregnancy rates among 
male partners with oligospermia in which the outcome 
was 47.8%, 36.4% and 20% in IVF, ICSI, and IUI 
respectively, with no significant statistical difference (P 
value = 0.304). The pregnancy rate of male partners 
with asthenospermia in IVF, ICSI, and IUI was 53.8%, 
32.0%, and 13.3% respectively. There was no 
significant difference (P value = 0.072). Males with 
teratozoospermia only gets pregnant by ICSI in which 
pregnancy rate was 60% but not statistically 
significant (P value = 0.387). The pregnancy rate was 
30.4% in smokers and 34.7% in nonsmokers with no 
significant statistical difference (P value = 0.808). 
Pregnancy rate was 43.9% among women with 
secondary infertility vs. 28.3% in those with primary 
infertility (P value = 0.104). The highest rate of 
gestation was reported among females taking 
Menogon 43.5% followed by Gonal-f 32.5%, then 
Fostimon and Clomid which were 25.0% with no 
significant statistical differences (P value = 0.697). 
Table 3: Assisted Reproductive Technology outcome about 
various factors  
Character Pregnant% 
Non-
pregnant % P-value* 
Males with 
oligospermia (n = 
88) 
ICSI 36.4% 63.6% 0.304 
IVF 47.8% 52.2% 
IUI 20% 80% 
Males with 
asthenospermia (n 
= 78) 
ICSI 32.0% 68.0% 0.072 
IVF 53.8% 46.2% 
IUI 13.3% 86.7% 
Males with 
teratospermia (n = 
38) 
ICSI 60% 40% 0.387 
IVF 0 100% 
IUI 0 100% 
Smoking: (n = 115) 
Yes 30.4% 13.9% 0.808 
No 34.7% 52.2% 
Type of infertility: (n 
= 115) 
Primary 28.3% 71.7% 0.104 
Secondary 43.9% 56.1% 
Medications of 
ovulation induction: 
(n = 115) 
Menogon 43.5% 56.5% 0.697 
Gonal-f 32.5% 67.5% 
Fostimon 25.0% 75.0% 
Clomid 25.0% 75.0% 
 
 
Discussion 
 
In the present study, retrospectively 115 
couples with male factor problems were recruited, and 
the woman had no identifiable infertility factor to make 
the differences in sperm parameters more significant. 
ART has become widespread treatments for 
alleviating male factor infertility, Different methods 
(IUI, IVF, and ICSI) are recommended, and the 
pregnancy rate depends mainly on sperm parameters 
such as sperm concentration, motility and morphology 
[14]. There is a positive correlation between sperm 
concentration and pregnancy [5]. 
The current data showed no statistical 
difference between various seminal abnormalities and 
pregnancy outcomes, the overall reported pregnancy 
rates were higher in IVF followed by ICSI and then IUI 
(46.4%, 35.5%, and 16% respectively) but there is no 
significant statistical difference between various 
methods P=0.061. In contradictory to Kastrop PM et 
al. [15]
 
concluded that ICSI appeared to be far better 
to IVF attempt. When using IUI the present findings, 
16% were more or less similar compared to Allen et 
al. who observed pregnancy rates between 8% and 
22% [16]. 
In this study, pregnancy was achieved when 
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sperm concentration was above 10 million/ml when 
using IUI. The lowest pregnancy rate achieved 
through IUI with oligospermia and asthenospermia 
(20% and 13.3%) but these values are acceptable 
when IUI is considered as a first-line treatment 
because it is simple, cost-effective and less invasive 
treatment option forms of assisted reproduction [17]. 
Cohlen BJ. State that a significant increase in 
pregnancy rates after IUI compared to timed 
intercourse in an infertile male
 
[18]. For this reasons, it 
must be attempted in these groups of patients before 
proceeding to more expensive and invasive methods 
such as IVF or ICSI
 
[19].  
IVF was introduced as a treatment for tubal 
infertility; it quickly became apparent that it was also 
an excellent option for male subfertility. In the current 
study IVF had a higher pregnancy rate than the others 
in cases of oligospermia and asthenospermia which 
were 47.8%, and 53.8%, respectively. ICSI success 
rate was lower 36.4% and 32.0% with the same 
sperm abnormalities but these results with no 
significant difference. From these results for all the 
above three modalities of treatment, IVF had a higher 
success rate in our centre. The use of ICSI as the first 
option for all cases of male factor infertility becomes a 
routine trend, although is concerned regarding its 
safety [20]. ICSI is a more invasive procedure that 
associated with a higher time demands and costs and 
bypasses the natural mechanisms [21].
 
Analysis of 
three RCTs could not show any significant benefit of 
ICSI over IVF [22]. Thus, IVF can be considered as 
the second line of treatment, if no conception 
achieved after 3-4 cycles of IUI, no need for 
unnecessarily switching over to ICSI.  
ICSI has completely changed the treatment of 
some forms of azoospermia. In obstructive 
azoospermia with surgical failure, spermatozoa may 
be recovered from either the testis or epididymis. In 
our study, ICSI has helped many couples with severe 
male factor infertility as in azoospermia and 
teratozoospermia to achieve pregnancies, so could be 
preserved to those mentioned abnormalities in which 
no pregnancy attained by either IVF or IUI although 
there is no statistically significant.  
Previous literature [23] confirmed the adverse 
effects of smoking on the results of IVF and ICSI, in 
the present study the pregnancy rate was slightly 
lower among those who smoke but not reaching 
statistical significance. In the present study, there was 
no difference in the pregnancy outcomes between 
females with primary or secondary infertility by 
previous research [24]. Menogon associated with 
highest pregnancy rate 43.5% compared to other drug 
but no statistical significance. Inconsistent to the result 
stated by Lee C. et al. that Gonal-f resulted in a higher 
pregnancy rate [25].
 
 
The Study limitations were that: it was a 
retrospective study, it was conducted at a single 
centre so generalization cannot be assured. 
Furthermore, the cumulative success rate of different 
ART methods was not included in the paper.  
Infertility is a subject of debate. Although 
there are considerable researches done on the 
infertile female, further larger, prospective, multicenter 
studies to address male factor infertility are highly 
needed.  
In conclusion, there was no significant 
statistical difference in pregnancy outcomes regarding 
various assisted reproductive techniques, smoking, 
type of infertility and medications.  
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